Öz
The
health-producing pharmaceutical sector, which meets one of the most basic needs
of individuals, has developed at a significant level to improve the quality of
life for individuals. Today, the pharmaceutical industry is a global industry
with great economic potential and incurring high R & D costs. As in the
other industrial units of the economy, a state of intense competition exists in
the pharmaceutical sector. In this study, domestic and foreign manufacturers
operating in Turkey are determined and it is aimed to determine the competitive
condition of the pharmaceutical industry with the obtained data from the companies.
Also, a frequency analysis was carried out to generally evaluate the opinions
of manufacturers and suppliers in the sector regarding the competitive
situation. T-test was conducted to determine whether there was a difference
between two groups in terms of the competitive situation. As a result, a
statistically significant difference was found between the manufacturers and
the suppliers.
Anahtar Kelimeler
Industry Analysis Pharmaceutical Industry Competitive Analysis Survey Analysis
Kaynakça
- Adrian, T. and David, H. (1995). Industrial Policy and the Pharmaceutical Industry (London: Office of Health Economics)
- Akbolat, M. and Işık, O. (2012). Hastanelerde Rekabet Stratejileri ve Performans. Atatürk Üniversitesi Sosyal Bilimler Enstitüsü Dergisi 2012 16 (1): 401-424
- Akın, C.S. (2007). Sağlık ve Sağlık Harcamalarının Ekonomik Büyüme Üzerine Etkisi: Türkiye’de Sağlık Sektörü Harcamaları. YYLT, Adana, Çukurova Üniversitesi, SBE.
- Brand Finance, Pharma 10, The Annual Report On The Most Valuable and Strongest Pharma Brands, February 2019
- Doğan, İ.F., Bakan, İ. and Hayva, S. (2017). Sağlık Sektörünün Temel Aktörleri Olan Hastanelerde Rekabet Stratejilerinin Kaliteye Etkisi
- Forbes (2017) The World’s Biggest Public Companies, https://www.forbes.com/global 2000/list/#industry: Pharmaceuticals date accessed: 08/04/2018
- İlaç Endüstrisi İşverenler Sendikası (İEİS), 2016 http://www.ieis.org.tr/ieis/tr/indicators/ 32/dunya-ilac-pazari, date accessed: 09/04/2018
- İlaç Endüstrisi İşverenler Sendikası (İEİS), 2017 January – March, Türkiye İlaç Pazarı, p.2
- ISO (2016), ISO İlk ve İkinci 500 Sanayi Kuruluşları, http://www.iso500.org.tr/, date accessed: 12/04/2018
- Karakoç, H.D. (2005). İlaç Sektöründe Fiyat Rekabeti. Rekabet Kurumu, Ankara.
- Kaynak, S. (2016). Türk İlaç Sektörünün Rekabet Yapısı ve Yoğunlaşma Analizi. Ondokuz Mayıs Üniversitesi İktisadi ve İdari Bilimler Fakültesi
- KPMG, 2018. Sektörel Bakış – İlaç, date accessed: 10/04/2018
- Levy, R. (1999), The Pharmaceutical Industry. A Discussion of Competitive and Antirust Issues in an Environment of Change, March, 1999
- OECD (2003). Regulatory Reform Review of Germany (DAFFE/COMP/WP2(2003)7). Working Party No. 2 on Competition and Regulation, Review of Germany.
- Sarsın Kaya, D. (2016). İlaç Sektörü, January 2016, p.9, 16, 17
- Scherer, F.M. and D. Ross (1990) Industrial Market Structure and Economic Performance, Houghton Mifflin Co., Boston
- Trade Map, https://www.trademap.org/ date accessed: 08/04/2018
- Turkish Republic, Department of Science and Industry (2015). Strateji Belgesi ve Eylem Planı: Türkiye İlaç Sektörü. 2015-2018, p.9
- Turkish Republic, Department of Science and Industry (2016). Sektörel Rapor ve Analizler: İlaç Sektörü raporu, p.8, 14
- W. Roberts, P. (1999), Product Innovation, Product- Market Competition and Persistent Profitability in the U.S. Pharmaceutical Industry
Öz
One of the most basic needs of individuals, the
pharmaceutical industry, which produces health-oriented products, has improved
significantly to improve the quality of life of individuals. Nowadays, the
pharmaceutical industry is a global industry with high economic potential and
with high R & D costs. As in other industrial units of the economy, the
intense competition environment is becoming more and more important for the
pharmaceutical sector. In this study, domestic and foreign manufacturers
operating in Turkey are determined and it is aimed to determine the competitive
condition of the pharmaceutical industry with the obtained data from the
companies. Also, a frequency analysis was carried out to generally evaluate the
opinions of manufacturers and suppliers in the sector regarding the competitive
situation. T-test was conducted to determine whether there was a difference
between two groups in terms of the competitive situation. As a result, a
statistically significant difference was found between the manufacturers and
the suppliers.
Anahtar Kelimeler
Industry Analysis Pharmaceutical Industry Competitive Analysis Survey Analysis Turkey
Kaynakça
- Adrian, T. and David, H. (1995). Industrial Policy and the Pharmaceutical Industry (London: Office of Health Economics)
- Akbolat, M. and Işık, O. (2012). Hastanelerde Rekabet Stratejileri ve Performans. Atatürk Üniversitesi Sosyal Bilimler Enstitüsü Dergisi 2012 16 (1): 401-424
- Akın, C.S. (2007). Sağlık ve Sağlık Harcamalarının Ekonomik Büyüme Üzerine Etkisi: Türkiye’de Sağlık Sektörü Harcamaları. YYLT, Adana, Çukurova Üniversitesi, SBE.
- Brand Finance, Pharma 10, The Annual Report On The Most Valuable and Strongest Pharma Brands, February 2019
- Doğan, İ.F., Bakan, İ. and Hayva, S. (2017). Sağlık Sektörünün Temel Aktörleri Olan Hastanelerde Rekabet Stratejilerinin Kaliteye Etkisi
- Forbes (2017) The World’s Biggest Public Companies, https://www.forbes.com/global 2000/list/#industry: Pharmaceuticals date accessed: 08/04/2018
- İlaç Endüstrisi İşverenler Sendikası (İEİS), 2016 http://www.ieis.org.tr/ieis/tr/indicators/ 32/dunya-ilac-pazari, date accessed: 09/04/2018
- İlaç Endüstrisi İşverenler Sendikası (İEİS), 2017 January – March, Türkiye İlaç Pazarı, p.2
- ISO (2016), ISO İlk ve İkinci 500 Sanayi Kuruluşları, http://www.iso500.org.tr/, date accessed: 12/04/2018
- Karakoç, H.D. (2005). İlaç Sektöründe Fiyat Rekabeti. Rekabet Kurumu, Ankara.
- Kaynak, S. (2016). Türk İlaç Sektörünün Rekabet Yapısı ve Yoğunlaşma Analizi. Ondokuz Mayıs Üniversitesi İktisadi ve İdari Bilimler Fakültesi
- KPMG, 2018. Sektörel Bakış – İlaç, date accessed: 10/04/2018
- Levy, R. (1999), The Pharmaceutical Industry. A Discussion of Competitive and Antirust Issues in an Environment of Change, March, 1999
- OECD (2003). Regulatory Reform Review of Germany (DAFFE/COMP/WP2(2003)7). Working Party No. 2 on Competition and Regulation, Review of Germany.
- Sarsın Kaya, D. (2016). İlaç Sektörü, January 2016, p.9, 16, 17
- Scherer, F.M. and D. Ross (1990) Industrial Market Structure and Economic Performance, Houghton Mifflin Co., Boston
- Trade Map, https://www.trademap.org/ date accessed: 08/04/2018
- Turkish Republic, Department of Science and Industry (2015). Strateji Belgesi ve Eylem Planı: Türkiye İlaç Sektörü. 2015-2018, p.9
- Turkish Republic, Department of Science and Industry (2016). Sektörel Rapor ve Analizler: İlaç Sektörü raporu, p.8, 14
- W. Roberts, P. (1999), Product Innovation, Product- Market Competition and Persistent Profitability in the U.S. Pharmaceutical Industry
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Bölüm | Araştırma Makaleleri |
| Yazarlar | |
| Yayımlanma Tarihi | 30 Ekim 2019 |
| Kabul Tarihi | 10 Eylül 2019 |
| Yayımlandığı Sayı | Yıl 2019 Ekim 2019 Özel Sayısı |
IBAD Sosyal Bilimler Dergisi / IBAD Journal of Social Sciences